View drug registration information details.


ItemsRegistration information
ID542
No542
Brand NameLOPID
IngredientsGEMFIBROZIL 600 MG
Dosage FormTABLET
Primary PackagingPVC-ALU BLISTER
StorageSTORE BELOW 30'C
Shelf Life60 MONTHS
Pack SizeBOX OF 6 X 10'S
Dispensing CategoryPrescription only
ATC ClassificationB04AC04
Pharmaceutical ClassLIPID MODIFYING
IndicationsGEMFIBROZIL IS A LIPID REGULATIONG AGENT THAT IS INDICATED FOR THE FOLLOWING : PRIMARY PREVENTION OF CORONARY HEART DISEASE (CHD) AND MYOCARDIAL INFARCTION (MI) IN PATIENTS WITH HYPERCHOLESTEROLEMIA, MIXED DYSLIPIDEMIA AND HYPERTRIGLYCERIDEMIA, FREDRICKSON'S CLASSIFICATION TYPES IIA, IIB AND IV.
ContraindicationsGEMFIBROZIL IS CONTRAINDICATED IN PATIENTS WITH HEPATIC OR SEVERS RENAL DYSFUNCTION, PRE EXISTING GALLBLADDER DISEASE, AND PATIENTS WHO ARE HYPERSENSITIVE TO GEMFIBROZIL OR ANY OF THE INERT INGREDIENTS
Side EffectsHEPATOBILIARY DISORDERS : CHOLESTATIC JAUNDICE.
Unit PriceUSD 4.41/B
EDL Yes
DescriptionA WHITE -COATED, ELLIPTICAL, BICONVEX TABLETS WITH MONOGRAM '' LOPID'' ON ONE SIDE AND PLAIN ON THE OTHER SIDE.
Note
License OwnerDKSH LAOS COMPANY LIMITED
ManufacturerOLIC (THAILAND) LIMITED
CountryTHAILAND
Import Registration No1A 421/40
Import Registration Date1997-05-29
ActivityCERTIFICATE RELEASED
Applied Date2024-03-06
FDD Registration No11 I 3994/13
FDD Registration Date2024-06-22
Expiry Date2027-06-21

Back to drug list